The Removing Barriers and Reducing Stigma to Encourage HIV Prevention Amendment Act of 2025 aims to enhance access to pre-exposure prophylaxis (PrEP), a critical HIV prevention medication, by prohibiting discrimination from insurance companies based on its use. The bill amends the Prohibition of Discrimination in the Provision of Insurance Act of 1986 to ensure that life, disability, and long-term care insurance policies cannot factor in the use of PrEP when making decisions about policy issuance, renewal, or terms. This legislation is designed to reduce stigma associated with HIV and encourage individuals at risk to utilize PrEP without fear of insurance repercussions.

Key provisions of the bill include the addition of a definition for PrEP, which encompasses both oral and injectable forms of the medication, and the establishment of penalties for insurers who violate these prohibitions, with fines ranging from $1,000 to $10,000 per violation. By enacting this legislation, the Council of the District of Columbia seeks to align with public health goals to reduce new HIV diagnoses and promote equitable treatment for individuals using preventive measures against HIV.